Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 31 results for "kiran mazumdar shaw"

Nandan Nilekani will not draw salary as Infosys Chairman: Report
Money Control

Nandan Nilekani will not draw salary as Infosys Chairman: Report

According to a Deccan Herald report, Kiran Mazumdar-Shaw, board director and head of the Nominations and Remuneration Committee (NRC), said Nilekani will not receive any remuneration "as per his request”. Money Control, 3 weeks ago

16 images for kiran mazumdar shaw

Money Control, 4 weeks ago
Money Control, 4 weeks ago
Money Control, 2 weeks ago
MSN India, 3 weeks ago
Money Control, 2 months ago, 7 months ago
Money Today, 4 months ago
Business Standard, 7 months ago
Financial Express, 7 months ago
DealStreetAsia, 7 months ago
MSN India

Infy crisis: Kiran Mazumdar-Shaw backs Ravi Venkatesan

Amidst attacks on Ravi Venkatesan by some stakeholders, Infosys independent director Kiran Mazumdar-Shaw today came out in his support saying he was a valuable board member. "It is most unfair for people to demand his resignation. He is indeed a very valuable ...
 MSN India3 weeks ago Infosys row: Kiran Mazumdar-Shaw backs Ravi Venkatesan after Pai's remarks  Business Standard3 weeks ago
Money Control

Biocon to address French regulator concerns in a quarter: Mazumdar Shaw

Kiran Mazumdar Shaw, chairman and managing director of Biocon says that India's largest Biopharma company will take remedial measures at its drug product facility within a quarter and ask the French medical regulator to inspect its facility again to get ...
 Business Standard2 months ago GST may lead to drug shortage;chemists not keeping stock:Shaw  DNA2 months ago People are very concerned about the complexity of GST: Kiran Mazumdar Shaw  Money Control2 months ago Disappointed at multi-tiered approach of GST: Mazumdar-Shaw  DNA2 months ago

GST impact: Pharma sector supply chain coping well after rollout

Time is needed to prepare for commercial launch of the new products: Biocon CMD Kiran Mazumdar Shaw
 Business Standard2 months ago GST impact: Supply chain in pharma sector seems to be coping post rollout  Business Standard2 months ago Supply chain in pharma sector seems to be coping post-GST: Biocon  Sify2 months ago

Meet IBM's Transformation Man

'My simple instruction to every IBM salesperson is, "When you go to the customer, use less of this (he points to his mouth) and more of this (ear)".''Talk less, listen more",' Karan Bajwa tells Raghu Krishnan.Illustration: Dominic Xavier/   The top boss at IBM in the country has always had his base in Bengaluru, from where the global tech major runs its massive operations for India and the world. Not Karan Bajwa, who took charge as managing director of IBM India in January. The ...
 Rediff.com2 weeks ago

Who will be the next Infosys CEO?

Infy to cast wide net in CEO search, may go back to 'alumni' Former Infoscions may well have a shot at clinching the top job as Infosys CEO, with the company looking at "alumni" along with internal and external candidates in its global search for the lead role. Within hours of taking charge as Infosys non-executive chairman, Nandan Nilekani told investors on Friday that Infosys was going to "cast a very wide net" globally to get the best talent onboard. "We are looking at internal candidates, ...
 Rediff.com4 weeks ago

Infy announces buyback worth Rs 13,000 cr at price of Rs 1,150 per share

The board of India's second-largest IT company Infosys on Saturday approved buyback worth Rs 13,000 crore, at a premium of 19.08% and 18.70% over the weighted average market price on BSE and NSE respectively. The board, in its first meeting after the ...
 Deccan Herald1 month ago

Karnataka announces single mega event for IT, BT industries in November

Karnataka is doing away with its multitude of technology events and plans to hold a single mega meet in Bengaluru this November with the goal of promoting collaboration between various tech focused industries.The move made by Karnataka's IT, BT & Science & ...
 Business Standard1 month ago

Biocon shares end over 2% lower after Q1 results

The scrip of bio-pharmaceutical firm Biocon today ended over 2 per cent lower after the company reported a 51.20 per cent decline in consolidated net profit for the quarter ended June. Trimming much of its early losses, the stock ended at Rs 390.15, down 2.24 ...
 Business Standard1 month ago Biocon shares drop 7 pc as Q1 net profit slumps  Business Standard1 month ago Biocon's q1 slump adds to misery for pharma stocks  Sify1 month ago

5 yrs after shelving it, govt reviving ambitious elevated road plan

The state government is reviving an ambitious elevated road corridor project in Bengaluru that was shelved five years ago after it was found financially unviable: It is likely to take up the project by introducing toll. Karnataka Road Development Corporation ...
 Deccan Herald1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less